Arbor Trust Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Arbor Trust Wealth Advisors's ABBV Position: Q3 2026 in Review
Arbor Trust Wealth Advisors increased its AbbVie (ABBV) stake by 1% in Q3 2026, buying an estimated $109K and bringing the position to 43,087 shares worth $11.3M. The position accounts for 4.37% of the portfolio, ranked #4.
Arbor Trust Wealth Advisors first reported a position in ABBV in Q4 2019 and has held it in 28 quarters since. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Arbor Trust Wealth Advisors held 43,087 shares of AbbVie worth $11.3M as of Q3 2026.
- Arbor Trust Wealth Advisors bought 427 AbbVie shares in Q3 2026, an estimated $109K.
- AbbVie made up 4.37% of Arbor Trust Wealth Advisors's portfolio in Q3 2026, its #4 holding.
- Arbor Trust Wealth Advisors first reported a position in AbbVie in Q4 2019 and has held it in 28 quarters since.
- 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Arbor Trust Wealth Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.